Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations.

MLA

Madeline H Kowalski, et al. “Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium Whole Genome Sequences Improves Imputation Quality and Detection of Rare Variant Associations in Admixed African and Hispanic/Latino Populations.” PLoS Genetics, vol. 15, no. 12, Dec. 2019, p. e1008500. EBSCOhost, https://doi.org/10.1371/journal.pgen.1008500.

APA

Madeline H Kowalski, Huijun Qian, Ziyi Hou, Jonathan D Rosen, Amanda L Tapia, Yue Shan, Deepti Jain, Maria Argos, Donna K Arnett, Christy Avery, Kathleen C Barnes, Lewis C Becker, Stephanie A Bien, Joshua C Bis, John Blangero, Eric Boerwinkle, Donald W Bowden, Steve Buyske, Jianwen Cai, … Yun Li. (2019). Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations. PLoS Genetics, 15(12), e1008500. https://doi.org/10.1371/journal.pgen.1008500

Chicago

Madeline H Kowalski, Huijun Qian, Ziyi Hou, Jonathan D Rosen, Amanda L Tapia, Yue Shan, Deepti Jain, et al. 2019. “Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium Whole Genome Sequences Improves Imputation Quality and Detection of Rare Variant Associations in Admixed African and Hispanic/Latino Populations.” PLoS Genetics 15 (12): e1008500. doi:10.1371/journal.pgen.1008500.